相关实验视频

Updated: May 5, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

结构性特征,Trichosanthes kirilowii Maxim的新型多糖体对糖尿病病的保护作用. 佩里卡尔皮 (Pericarp) 是一个大心脏地带

Kunpeng Zhang¹, Qiaoying Song¹, Hankui Wu¹

¹College of Biotechnology and Food Science, Anyang Institute of Technology, Anyang, China.

Chemistry & biodiversity

|September 27, 2025

概括

特里科桑提斯基里洛维马克西姆. 佩里卡帕多糖 (TMPP) 提取物TMPP-1通过改善小鼠的高血糖,脂质水平,氧化应激和免疫反应来治疗糖尿病病 (DN) 的潜力.

科学领域:

药理学药理学是指药理学的学科.
生物化学生物化学
自然产品化学化学

背景情况:

糖尿病病 (DN) 是糖尿病的一种严重并发症,其特征是损伤.
探索天然化合物对DN的治疗潜力至关重要.

研究的目的:

为了研究Trichosanthes kirilowii Maxim的治疗作用. 在糖尿病脏病 (DN) 的小鼠中,脏功能的周周多糖 (TMPP),特别是纯化的 TMPP-1 分数.
阐明TMPP-1的结构特征和潜在机制.

主要方法:

从T. kirilowii Maxim.中提取和净化TMPP和TMPP-1. 周围的. 周围的.
使用FT-IR,HPLC,GC和NMR对TMPP-1的结构性表征.
在体内评估TMPP-1对DN小鼠高血糖,脂质样本,氧化应激和免疫反应的影响.

主要成果:

TMPP-1是一种分子量为4.52kDa的多糖,由Man,Glc和Gal组成.
结构分析揭示了TMPP-1内部的特定的葡萄糖酸链接.
在DN小鼠中,TMPP-1治疗显著缓解了高血糖症,改善了脂质水平,减少了氧化应激,并调节了免疫反应.

结论:

TMPP-1在改善与糖尿病病相关的临床症状方面显示出显著的治疗潜力.
这项研究支持使用T. kirilowii Maxim. 骨副产品作为新型治疗剂的来源.

关键词:

在SPF雄性小鼠中.特里科桑提斯基里洛维马克西姆. 周围心脏 (pericarp) 的一个部分.糖尿病性脏病糖尿病性脏病结构性特征的结构性特征.

更多相关视频

Comparative Study on the Polysaccharide Contents and Antioxidant Activities of Hippophae rhamnoides subsp. sinensis and Hippophae gyantsensis

Comparative Study on the Polysaccharide Contents and Antioxidant Activities of Hippophae rhamnoides subsp. sinensis and Hippophae gyantsensis

Published on: August 15, 2025

相关概念视频

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...

Diabetic Nephropathy

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...